BioCrossroads Newsadmin41332021-03-19T10:05:37-04:00

BIOCROSSROADS NEWS/EVENTS

BioCrossroads is excited to announce the annual Indiana Life Sciences Summit, scheduled for November 7, 2024, at the Biltwell Event Center in Indianapolis. The Summit will focus on “Transforming Healthcare: Indiana’s Role in Revolutionizing Diabetes and Obesity Management,” highlighting Indiana’s significant impact on healthcare, particularly in the development of GLP-1 therapies, which are revolutionizing diabetes and obesity care, and the opportunities that lie ahead for continued advancement of future therapies.

July 16, 2024

BioCrossroads announces the 2024 Indiana Life Sciences Summit, “Transforming Healthcare: Indiana’s Role in Revolutionizing Diabetes and Obesity Management”

BioCrossroads 2023 Indiana Life Sciences Capital Report

May 6, 2024

Indiana solidifies leadership in Life Sciences with remarkable growth in 2023

Vince Wong, president and CEO of BioCrossroads

January 31, 2024

BioCrossroads Welcomes Vince Wong as President and CEO

BioCrossroads unveils A Strategic Roadmap for Advancing Indiana's Life Sciences Industries study

January 8, 2024

Igniting an Industry: A Strategic Vision for Indiana’s Future as a Global Leader in Life Sciences

IU School of Medicine’s Bruce Lamb named BioCrossroads’ 2023 Watanabe Life Sciences Champion

November 9, 2023

IU School of Medicine’s Bruce Lamb named BioCrossroads’ 2023 Watanabe Life Sciences Champion

BioCrossroads Indiana Life Sciences Summit 2023

October 16, 2023

BioCrossroads’ annual Life Sciences Summit to showcase Indiana’s leadership role in the battle against Alzheimer’s disease

CICP launches search for new BioCrossroads President and CEO

September 11, 2023

CICP launches search for new BioCrossroads President and CEO

BioCrossroads Book of Data and Organizations

May 9, 2023

BioCrossroads Book of Data and Organizations goes digital to serve as Indiana’s wiki for health data assets

April 27, 2023

BioCrossroads adds new members to Board of Directors

BioCrossroads 2022 Indiana Life Sciences Capital Investment Report

April 17, 2023

BioCrossroads releases 2022 Indiana Life Sciences Capital Report showing $6.8B in capital investment in the life sciences sector 

Mike Bolinder and Jane Dunigan-Smith added to BioCrossroads leadership team.

March 21, 2023

BioCrossroads names new members to leadership team

BioCrossroads and Ascend Indiana release new white paper on pharmaceutical manufacturing and talent

March 9, 2023

White Paper: Recruiting and retaining talent who make life-saving medicine; State of Pharmaceutical Manufacturing Workforce in Indiana